Our Team

Dr. Henry Lowe, PhD. Director & Executive Chairman.
Dr. Lowe is internationally recognized for his research in the field of drug discovery and development. His experience includes being the Chairman & CEO of Blue Cross Blueshield of Jamaica. Dr. Lowe hold a PhD in Medicinal Chemistry (Manchester University, UK) and is the co-author of several peer-reviewed articles and holder of 12 patents on his scientific inventions. Dr. Lowe is also the Executive Chairman of Flavocure Biotech, Inc.

Dr. Ngeh Toyang, PhD. Director & Executive Vice Chairman.
Dr. Toyang’s research experience spans research institutions including the National Center for Natural Products Research at the University of Mississippi School of Pharmacy; Natural Products Research Laboratory of the University of Leiden, The Netherlands, and the Institute of Human Virology at the University of Maryland School of Medicine. Dr. Toyang holds a PhD degree specializing in Pharmacognosy from Leiden University, The Netherlands. He is the co-author of over 30 peer-reviewed scientific articles and holds 9 patents on his scientific inventions. Dr. Toyang is also the CEO of Flavocure Biotech, Inc.

Dr. Shepard C. Shepard, MD FACP. Interim- Chief Medical Officer. Dr. Shepard has extensive expertise in clinical research and development of cancer drugs. Very recently, had been the global lead medical director for both a phase III registration trial in breast cancer as well as a phase I/II trial in prostate cancer for AstraZeneca, and in strategic development for MedImmune. Dr. Shepard graduated Magna cum Laude in Biochemical Sciences and Molecular Biophysics from Harvard, followed by a year in the Harvard-M.I.T. Health Sciences Program, and later earned his MD degree in the Medical Scientist Training M.D.-Ph.D. Program at Duke University School of Medicine.

Dr. Luchuo E. Bain, MD PhD, MBA. Assistant Director, Medical Affairs.
Dr. Bain is an epidemiologist and global health physician. He has clinical and global health research experience in sub – Saharan Africa, Europe and North America. Luchuo has served as a consultant for international organizations including the WHO, The UNFPA, and the UK Foreign development Office (FCDO). He earned an MD degree from the University of Yaounde 1 in Cameroon, an MPH in Epidemiology from the Hebrew University of Jerusalem, Israel, a Master of Bioethics from KU Leuven in Belgium, and an MBA from the Universidad Internacional de la Rioja in Spain, and PhD in transdisciplinary global health solutions from the Vrije Universiteit, Amsterdam, in the Netherlands. He has over 85 peer reviewed scientific publications.

Dr. Thomas Lang, PhD MBA. VP Quality & Regulatory Affairs. Dr. Lang is an experienced pharmaceutical and biotech industry veteran, graduating with degrees in Chemistry, Pharmacy PhD and MBA. Dr. Lang previously served as the President and Vice Chairman of Serono, Inc., a biopharmaceutical business headquartered in Geneva, Switzerland. He has participated in the successful development and commercialization of 12 products in the areas of HIV/AIDS, Infertility and Reproductive Health, Growth, Metabolism and Endocrinology, CNS, Surgical Muscle Relaxants, Allergy Immunotherapy, and Multiple Sclerosis. At Flavocure he oversees the implementation of all IND-enabling studies and preparation of the IND filing package with the FDA.

Rose Financial Solutions, CFO. LTN Pharma hired Rose Financial Solutions (RFS) to handle its financial and accounting needs. RFS provides innovative solutions designed to support LTN Pharma grow. Through RFS removes roadblocks by giving LTN Pharma the financial confidence needed to make sound business decisions and achieve more. Through RFS’s cloud-based systems and advanced technology Easby® powered by RFSWorkflow™, RSF ensures LTN Pharma has a cost-effective and scalable financial infrastructure that starts with getting the bookkeeping done right. RFS was founded and is led by Ted Rose who graduated from the University of Maryland with a B.S. in Accounting and a M.B.A in Finance and International Business. He serves on the Accounting and Information Assurance Board for the Robert H. Smith School and participates as a guest lecturer for the business school.

Ravi Bobby Takyar. Director.
Investor, with great vision for humanitarian services, happy to strive with LTN Phama worldwide to improve Healthcare quality to the needy and underprivilage community. Our commitment to promote, educate and develop infrastructure in Latin America,, United Kingdom, Europe, Saudi Arabia, middle east and Africa

Bakary Yerima Arabo
Inspired with vision to collaborate with LTN Phama, in providing cutting edge Healthcare solutions, to people in Paraguay, Latin America and the world at large. Strategically, helping provide with LTN Phama high quality and affordable medication for the treatment of prostate and other cancers. Bakary is a retired professional soccer player and the founder and Chairman of Arabo Holdings, a Paraguan mega business enterprise

Dr Sandra Carrillo Physician, Professor Faculty of Medicine University of Panama(Head of Medical Cannabis Educational Program).
Certified in Regenerative Medicine, Research Epidemiology, Masters in Health Services Administration. Co-Founder Colombian Medical Cannabis Association, Medical Director at Medicann (Medical Cannabis Clinics in Colombia)

Prof. Wilfred Ngwa.
Dr. Ngwa is the PI for the Biomaterial Drones and Radio-immunotherapy Lab at Johns Hopkins Medicine & Director of the Global Health Catalyst dedicated to catalyzing high impact collaborations to eliminate cancer health disparities in the USA and globally. He completed his postdoctoral and clinical training at M.D. Anderson Cancer Center Florida, and Harvard Medical School. Dr. Ngwa obtained his PhD degree from University Leipzig Medicine Fak – Saxony (Germany)

Dr. Brylyne Chitsunge
Dr. Chitsunge is one of South Africa’s most successful commercial farmers and an internationally acclaimed expert in agribusiness. With a potent combination of medical and agricultural experience, Dr. Chitsunge is well placed to guide and assist in the development and progression of the medical industry, both locally in South Africa, and across the globe. She is very passionate about health and Phytomedicines research and is the Co-Chair of Phytomedicines with Global Health Catalyst, Harvard School of Medicine. Dr. Chitsunge was educated in the UK where she graduated with a PhD, specializing in Molecular Medicine and Biotechnology. Dr. Chitsunge is the Pan-African Parliament’s Ambassador for Food Security in Africa.

Prof. Vincent Njar, Distinguised Professor, University of Maryland Baltimore. Dr. Vincent Njar has a long-standing interest in the rational discovery and development of small molecules as anti-cancer agents. He is a leading medicinal chemist and oncopharmacologist who has made significant discoveries in the development of novel small molecules with potential for the treatments of a variety of cancers, especially breast, prostate and pancreatic cancers. Prof. Njar holds a PhD degree in Organic Chemistry from University of London.